Curaleaf Holdings (TSX:CURA) E10: C$-0.68 (As of Mar. 2026)


TSX:CURA Curaleaf Holdings Inc TSX:CURA
76 GF Score
Price C$13.32
GF Value C$11.39
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Curaleaf Holdings E10?

Curaleaf Holdings TSX:CURA -9.08% 76 E10 is C$-0.68 as of Mar. 2026. GuruFocus rates TSX:CURA with a GF Score™ of 76/100 and a GF Value™ of C$11.39 (Modestly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Curaleaf Holdings's adjusted earnings per share data for the three months ended in Mar. 2026 was C$0.370. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-0.68 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-06), Curaleaf Holdings's current stock price is C$13.32. Curaleaf Holdings's E10 for the quarter that ended in Mar. 2026 was C$-0.68. Curaleaf Holdings's Shiller PE Ratio of today is .


Curaleaf Holdings  (TSX:CURA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Curaleaf Holdings E10 Related Terms


Curaleaf Holdings E10 Historical Data

* Premium members only.

The historical data trend for Curaleaf Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaleaf Holdings E10 Chart

Curaleaf Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.61 -0.71

Curaleaf Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 -0.66 -0.69 -0.71 -0.68

TSX:CURA vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curaleaf Holdings Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Shiller PE Ratio falls into.


TSX:CURA
76GF Score
Curaleaf Holdings Inc TSX:CURA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curaleaf Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Curaleaf Holdings's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.37/330.2130*330.2130
=0.370

Current CPI (Mar. 2026) = 330.2130.

Curaleaf Holdings Quarterly Data

per share eps CPI Adj_EPS
201606 -0.088 241.018 -0.121
201609 -0.140 241.428 -0.191
201612 0.007 241.432 0.010
201703 -0.030 243.801 -0.041
201706 -0.061 244.955 -0.082
201709 0.184 246.819 0.246
201712 2.261 246.524 3.029
201803 -0.039 249.554 -0.052
201806 -0.039 251.989 -0.051
201809 -0.352 252.439 -0.460
201812 -0.121 251.233 -0.159
201903 -0.080 254.202 -0.104
201906 -0.199 256.143 -0.257
201909 -0.040 256.759 -0.051
201912 -0.237 256.974 -0.305
202003 -0.126 258.115 -0.161
202006 -0.015 257.797 -0.019
202009 -0.040 260.280 -0.051
202012 -0.192 260.474 -0.243
202103 -0.151 264.877 -0.188
202106 -0.110 271.696 -0.134
202109 -0.299 274.310 -0.360
202112 -0.154 278.802 -0.182
202203 -0.190 287.504 -0.218
202206 -0.115 296.311 -0.128
202209 -0.320 296.808 -0.356
202212 -1.467 296.797 -1.632
202303 -0.328 301.836 -0.359
202306 -0.399 305.109 -0.432
202309 -0.528 307.789 -0.566
202312 -0.362 306.746 -0.390
202403 -0.284 312.332 -0.300
202406 -0.247 314.175 -0.260
202409 -0.284 315.301 -0.297
202412 -0.572 315.605 -0.598
202503 -0.431 319.799 -0.445
202506 -0.328 322.561 -0.336
202509 -0.332 324.800 -0.338
202512 -0.547 324.054 -0.557
202603 0.370 330.213 0.370

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of C$-0.68 mean?
Curaleaf Holdings (TSX:CURA) has a E10 of C$-0.68 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Curaleaf Holdings and its competitors.
Is Curaleaf Holdings' E10 too high?
Curaleaf Holdings' current E10 is C$-0.68. Overall, Curaleaf Holdings has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' E10 compare to ZTS and UTHR?
Curaleaf Holdings' E10 of C$-0.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Curaleaf Holdings and its competitors. Curaleaf Holdings's current E10 is C$-0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (TSX:CURA) is currently considered Modestly Overvalued. The stock's GF Value™ is C$11.39, compared to a current price of C$13.32 — trading 16.9% above its estimated fair value. The current E10 is C$-0.68. Curaleaf Holdings' overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Curaleaf Holdings (TSX:CURA), the current E10 is C$-0.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (TSX:CURA) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of C$13.32 is trading 16.9% above its estimated GF Value™ of C$11.39. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for TSX:CURA:

  • E10: C$-0.68
  • GF Value™: C$11.39 vs. price of C$13.32 (16.9% above fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the TSX:CURA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Curaleaf Holdings Business Description

Other Exchanges CURLD:USA2XW:Germany
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
76GF Score

Get the complete analysis for TSX:CURA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$13.32
Price
C$11.39
GF Value